FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2065221837> ?p ?o ?g. }

• W2065221837 endingPage "2778" @default.
• W2065221837 startingPage "2771" @default.
• W2065221837 abstract "Background. The amplification and/or overexpression of the HER-2/neu oncogene has been proposed as an important prognostic marker in breast cancer. However, contradictory results from various groups regarding whether there is statistical significance in HER-2 amplification or overexpression in predicting overall and disease free survival in node positive versus node negative patients exist in the literature. Current assays on quantifying the HER-2 oncogene rely on DNA extracted from homogenized breast tissue. Not only is a large amount of tissue required, but also, the DNA extract is contaminated with DNA from stromal cells and leukocytes, leading to decreased specificity and sensitivity of the HER-2 assay. Improving the specificity (DNA from breast ductal cells) and the sensitivity (competitive polymerase chain reaction [PCR]) of the HER-2 amplification detection assay will help resolve some of these controversies. Methods. Using multiparameter flow cytometry (FCM), ductal cells from breast biopsies and fine needle aspirations (FNAs) are identified and selectively sorted using anti-cytokeratin, anti-HER-2 antibody labeling and DNA staining. HER-2 amplification in these sorted cells is then quantified by competitive DNA PCR using a competitive reference standard mutant template that is susceptible to the restriction enzyme Sma-1. Results. Applying this strategy, SK-BR-3, an HER-2 amplified breast cancer cell line, was found to have approximately 9X baseline HER-2 oncogene copies. In addition, MCF-7, a known HER-2 nonamplified breast cancer cell line, was found to have baseline HER-2 oncogene copies. In the 10 clinical breast samples tested, 4 of the 10 breast cancers were HER-2 amplified using as few as 1000 cells. The cytokeratin positive cells of these cancers, in contrast to the cytokeratin negative cells, have detectably higher HER-2 amplification (7.2 ± 2.8X versus 3.2 ± 1.1X, respectively). Hence, HER-2 gene amplification would have been underestimated if unsorted cells were used because of stromal dilution. In the cytokeratin positive cells that were HER-2 oncogene amplified, corresponding HER-2 oncoprotein overexpression was detected by FCM. Conclusions. Using FCM, the ductal cell subpopulation of a breast specimen can be successfully sorted from breast biopsy and FNA specimens. Moreover, by applying the technique of competitive PCR, improved specificity and sensitivity in HER-2 oncogene amplification detection is achieved. The entire procedure can be accomplished in 1 day, allowing for a cost-effective assay and rapid turnaround time. Cancer 1994; 73:2771–8." @default.
• W2065221837 created "2016-06-24" @default.
• W2065221837 creator A5034665794 @default.
• W2065221837 creator A5047534729 @default.
• W2065221837 creator A5050490946 @default.
• W2065221837 creator A5055291121 @default.
• W2065221837 creator A5060415186 @default.
• W2065221837 date "1994-06-01" @default.
• W2065221837 modified "2023-09-27" @default.
• W2065221837 title "Detection of HER-2/neu oncogene amplification in flow cytometry-sorted breast ductal cells by competitive polymerase chain reaction" @default.
• W2065221837 cites W1974559924 @default.
• W2065221837 cites W1983622635 @default.
• W2065221837 cites W1991311550 @default.
• W2065221837 cites W1991766587 @default.
• W2065221837 cites W2016693266 @default.
• W2065221837 cites W2038327083 @default.
• W2065221837 cites W2047575897 @default.
• W2065221837 cites W2055687655 @default.
• W2065221837 cites W2082057444 @default.
• W2065221837 cites W2111703821 @default.
• W2065221837 cites W2137371141 @default.
• W2065221837 cites W2141393790 @default.
• W2065221837 cites W2159363679 @default.
• W2065221837 cites W2291927913 @default.
• W2065221837 cites W2401248590 @default.
• W2065221837 cites W2475714682 @default.
• W2065221837 cites W2582935941 @default.
• W2065221837 cites W2893578584 @default.
• W2065221837 doi "https://doi.org/10.1002/1097-0142(19940601)73:11<2771::aid-cncr2820731120>3.0.co;2-k" @default.
• W2065221837 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7514954" @default.
• W2065221837 hasPublicationYear "1994" @default.
• W2065221837 type Work @default.
• W2065221837 sameAs 2065221837 @default.
• W2065221837 citedByCount "24" @default.
• W2065221837 crossrefType "journal-article" @default.
• W2065221837 hasAuthorship W2065221837A5034665794 @default.
• W2065221837 hasAuthorship W2065221837A5047534729 @default.
• W2065221837 hasAuthorship W2065221837A5050490946 @default.
• W2065221837 hasAuthorship W2065221837A5055291121 @default.
• W2065221837 hasAuthorship W2065221837A5060415186 @default.
• W2065221837 hasConcept C104317684 @default.
• W2065221837 hasConcept C121608353 @default.
• W2065221837 hasConcept C126322002 @default.
• W2065221837 hasConcept C142724271 @default.
• W2065221837 hasConcept C153911025 @default.
• W2065221837 hasConcept C2780849966 @default.
• W2065221837 hasConcept C2781018059 @default.
• W2065221837 hasConcept C29537977 @default.
• W2065221837 hasConcept C49105822 @default.
• W2065221837 hasConcept C502942594 @default.
• W2065221837 hasConcept C530470458 @default.
• W2065221837 hasConcept C54355233 @default.
• W2065221837 hasConcept C553184892 @default.
• W2065221837 hasConcept C71924100 @default.
• W2065221837 hasConcept C86803240 @default.
• W2065221837 hasConceptScore W2065221837C104317684 @default.
• W2065221837 hasConceptScore W2065221837C121608353 @default.
• W2065221837 hasConceptScore W2065221837C126322002 @default.
• W2065221837 hasConceptScore W2065221837C142724271 @default.
• W2065221837 hasConceptScore W2065221837C153911025 @default.
• W2065221837 hasConceptScore W2065221837C2780849966 @default.
• W2065221837 hasConceptScore W2065221837C2781018059 @default.
• W2065221837 hasConceptScore W2065221837C29537977 @default.
• W2065221837 hasConceptScore W2065221837C49105822 @default.
• W2065221837 hasConceptScore W2065221837C502942594 @default.
• W2065221837 hasConceptScore W2065221837C530470458 @default.
• W2065221837 hasConceptScore W2065221837C54355233 @default.
• W2065221837 hasConceptScore W2065221837C553184892 @default.
• W2065221837 hasConceptScore W2065221837C71924100 @default.
• W2065221837 hasConceptScore W2065221837C86803240 @default.
• W2065221837 hasIssue "11" @default.
• W2065221837 hasLocation W20652218371 @default.
• W2065221837 hasLocation W20652218372 @default.
• W2065221837 hasOpenAccess W2065221837 @default.
• W2065221837 hasPrimaryLocation W20652218371 @default.
• W2065221837 hasRelatedWork W2042520059 @default.
• W2065221837 hasRelatedWork W2467622083 @default.
• W2065221837 hasRelatedWork W2758639219 @default.
• W2065221837 hasRelatedWork W2772993264 @default.
• W2065221837 hasRelatedWork W2792929645 @default.
• W2065221837 hasRelatedWork W2803841817 @default.
• W2065221837 hasRelatedWork W2970671691 @default.
• W2065221837 hasRelatedWork W2989955996 @default.
• W2065221837 hasRelatedWork W3126656898 @default.
• W2065221837 hasRelatedWork W3147647031 @default.
• W2065221837 hasVolume "73" @default.
• W2065221837 isParatext "false" @default.
• W2065221837 isRetracted "false" @default.
• W2065221837 magId "2065221837" @default.
• W2065221837 workType "article" @default.